Find Academic Supervisors

Professor Rinse Weersma is a Full Professor and Gastroenterologist at the Faculty of Medical Sciences, University of Groningen, and works at the University Medical Center Groningen (UMCG). He leads research in the Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI), focusing on inflammatory bowel diseases and the gut microbiome. Faculty of Medical Sciences, University of Groningen University Medical Center Groningen (UMCG) Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI) Professor Weersma's research primarily centers on inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, with a strong emphasis on understanding the role of the gut microbiome, genetic factors, and immune responses. His work bridges gastroenterology, immunology, and microbiology to develop better diagnostic tools and treatment approaches for IBD patients. He has pioneered research on how diet, environmental factors, and host genetics interact to influence disease development and progression. Analysis of Professor Weersma's recent publications (2025) reveals a strong trend toward multi-omics approaches to understanding inflammatory bowel diseases. His research integrates microbiome analysis, genetic studies, and clinical data to identify biomarkers for disease prediction and treatment response. Key themes include the relationship between gut microbiome composition and IBD, gene-environment interactions, and the application of advanced statistical methods to dietary and clinical data. His work has significant implications for personalized medicine approaches in gastroenterology. Rising Star Award (2011) Professor Weersma actively supervises PhD students including Marjolein Klaassen and Laura Bolte, focusing on gut microbiome research in inflammatory bowel diseases. His research is supported by multiple collaborative projects including the 1000IBD project, which has generated extensive multi-omics data from IBD patients. He frequently collaborates with international research teams across Europe and has contributed to major studies on liver transplantation and microbiome interactions. His work has been funded through various national and international grants supporting gastrointestinal research. Professor Weersma leads research within the Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI), which brings together experts in gastroenterology, immunology, genetics, and microbiome research. His team collaborates extensively through the TransplantLines Investigators consortium and participates in large-scale international research initiatives studying inflammatory bowel diseases across diverse populations.

• Inflammatory Bowel Disease
• Gut Microbiome
• Crohn's Disease
• +5 more

Janneke Samsom is a Full Professor in the Department of Pediatrics at Erasmus MC, a leading academic medical center in the Netherlands. Her work is centered at the intersection of pediatric immunology and gastroenterology, with a strong emphasis on understanding immune dysregulation in inflammatory bowel diseases. Her research interests include mucosal immunology , T-cell differentiation , inflammatory bowel disease (IBD) , Crohn’s disease , regulatory and pathogenic T cells , and the discovery of biomarkers for treatment response . She investigates how memory T cells and plasma proteins can be profiled to define patient immunotypes, enabling personalized therapeutic strategies. The recent trend in her publications shows a strong focus on integrating proteomic and immunophenotypic data to predict disease progression and treatment outcomes in both pediatric and adult IBD. Her work spans from fundamental immunology to clinical translation, including case studies in rare immune disorders. Inflammatory Bowel Disease (IBD) Crohn's Disease Ulcerative Colitis T-cell Immunology Biomarker Discovery Pediatric Autoimmune Disorders She has supervised numerous junior researchers and students, contributing to a robust body of supervised academic work. Her collaborative network extends across Europe, with active research partnerships in immunology and gastroenterology. Dr. Samsom leads a research group focused on pediatric immune-mediated gastrointestinal diseases, contributing significantly to both national and international research initiatives.

• Immunology
• Pediatric Gastroenterology
• Inflammatory Bowel Disease
• +7 more

Prof. G. Dijkstra is a faculty member at the University of Groningen's Faculty of Medical Sciences, affiliated with the Nutrition Research in Medicine (NiM) department. His academic rank is Professor. He specializes in inflammatory bowel disease (IBD), Crohn's disease, and transplantation medicine. His research focuses on diet-nutrition interactions, biomarker discovery, and clinical outcomes in gastrointestinal disorders. He has been recognized with the Inspirator Prize (2024) from the Dutch Society 100%. Research interests include IBD pathophysiology, dietary impact on disease activity, and post-transplantation outcomes. Key collaborations include the Dutch Initiative on Crohn and Colitis (ICC) and the Groningen Institute for Organ Transplantation (GIOT). His work spans over 400 publications, emphasizing translational research and clinical applications. Recent studies explore biomarkers in pregnancy with IBD, dietary patterns predicting flares, and cellular signatures in intestinal grafts. He leads multidisciplinary teams addressing inflammation, oxidative stress, and surgical outcomes. Key articles from 2025 include diet-quality studies, Vedolizumab case reports, and risk stratification models for Crohn's recurrence. His work bridges basic science and clinical practice, with a focus on improving patient outcomes through personalized approaches.

• Inflammatory Bowel Disease
• Crohn's Disease
• Biomarkers
• +3 more

Ranko Gacesa is a researcher at the Faculty of Medical Sciences , University of Groningen , affiliated with the Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI) . His work focuses on gut microbiome interactions in diseases like inflammatory bowel disease (IBD), Crohn's disease, and coeliac disease, as well as post-transplantation complications. Research trends show expertise in metagenomics , microbial strain-level analysis , and non-HLA genetic mismatch studies in transplantation. He actively contributes to understanding dysbiosis and oral pathobiont colonization in diverse ethnic populations. Scientific Awards : Vidi grant for nutrition and gut microbiome research (2024) Supervision : Co-supervisor for Marjolein Klaassen's PhD research on gut microbiome in IBD

• Gut Microbiome
• Inflammatory Bowel Disease
• Microbiome
• +4 more

Prof. Cisca Wijmenga is a Professor of Human Genetics at the University of Groningen and Head of the Department of Genetics at the University Medical Center Groningen (UMCG). Her research focuses on the genetic basis of immune-related chronic diseases, particularly coeliac disease, inflammatory bowel diseases (Crohn’s and ulcerative colitis), and the role of the gut microbiome in health and disease. She has pioneered functional genomic approaches to understand disease mechanisms and translate genetic insights into clinical applications. Key achievements include Spinoza Prize (2015), election to the Royal Netherlands Academy of Arts and Sciences (2012), and leading the BBMRI-NL2.0 project (€9.8M grant, 2014). She served as Rector Magnificus of the University of Groningen from 2019–2023, becoming its first female rector in 405 years. Research interests emphasize genetic susceptibility to autoimmune disorders, host-microbiome interactions, and the application of organ-on-chip technologies. Collaborations span multi-omics analyses, biobanking, and international consortia (e.g., BBMRI, International Multiple Sclerosis Genetics Consortium). Grants/Awards: Spinoza Prize, KNAW Membership, ERC Advanced Grant Labs/Teams: Host-Microbiome Interaction Group, UMCG Genetics Department

• Human Genetics
• Immunology
• Genomics
• +3 more

Iris Barth is a researcher at the Faculty of Medical Sciences of the University of Groningen, affiliated with the Nutrition Research in Medicine (NiM) group. Her work focuses on nutrition-related clinical research in inflammatory bowel disease (IBD) and critical care rehabilitation. She contributes to the UN Sustainable Development Goals through health and well-being initiatives. Research Areas : Nutritional assessment tools for IBD, microbiome-diet interactions, vitamin supplementation in Crohn's disease, and post-ICU recovery interventions. Collaborations : Active in international research networks, with recent partnerships in dietary strategies for IBD. Her publications highlight methodological advancements in nutritional epidemiology, microbiome analysis, and evidence synthesis through systematic reviews. Current projects include the VITA-GrAID trial evaluating dietary interventions for Crohn's disease and randomized trials on ICU survivor outcomes. She employs interdisciplinary approaches merging clinical nutrition, patient-reported outcomes, and microbiota research. Research Output Trends : Emphasis on IBD management, anti-inflammatory diets, and microbiome modulation. Also explores protein supplementation and kinesiotherapy for ICU survivors.

• Nutritional Science
• Inflammatory Bowel Disease (IBD)
• Microbiome Research
• +5 more

Evelien Beelen is a Researcher at Erasmus MC, affiliated with the Department of Gastroenterology & Hepatology. Her work focuses on Crohn's disease, particularly in understanding recurrence post-surgery and optimizing pharmacological interventions. She has contributed to studies evaluating the efficacy of prophylactic medications, surgical timing, and anti-TNF therapies in managing postoperative recurrence. Her research emphasizes clinical risk stratification and comparative efficacy of treatments, aiming to improve patient outcomes in inflammatory bowel disease. Her collaborations include the Dutch Initiative on Crohn’s and Colitis (ICC) and multiple international researchers. Key areas of investigation involve postoperative recurrence mechanisms, therapeutic strategies, and prognostic factors in Crohn's disease. Publications span peer-reviewed journals such as Alimentary Pharmacology and Therapeutics and Clinical Gastroenterology and Hepatology , reflecting her commitment to advancing clinical gastroenterology.

• Crohn's Disease
• Inflammatory Bowel Disease
• Gastroenterology
• +3 more

Prof. Ruud Bank is a Professor at the Faculty of Medical Sciences, University of Groningen (UMCG), affiliated with the Groningen Kidney Center (GKC). His research focuses on tissue engineering, fibrosis mechanisms, and biomaterial applications in wound repair. He has extensive expertise in collagen biology, connective tissue diseases, and cell-matrix interactions. Additional roles: Board member of W.J. Kolff Stichting, Secretary of Rotary Hoogezand-Sappemeer, Treasurer of International Society of Matrix Biology (ISMB), Director of Ponteripa, and CSO at CollaneX Therapeutics. His work addresses fibrosis modulation in biomaterials, anti-fibrotic drug screening, and extracellular matrix dynamics. Recent studies explore high-throughput platforms for biomaterial evaluation and the role of matrix metalloproteinases in intestinal fibrosis. Bank has supervised 16 students and contributed to 86 research outputs, emphasizing translational research in regenerative medicine and fibrotic disorders. His lab (Groningen Kidney Center) collaborates internationally on biomaterials and fibrosis projects.

• Tissue Engineering
• Fibrosis
• Collagen Biology
• +9 more

Stanley Brul is Professor and Director of the College of Life Sciences at the University of Amsterdam's Faculty of Science, where he chairs the Molecular Biology & Microbial Food Safety group at the Swammerdam Institute for Life Sciences. Based at Science Park 904 (Room C3.263), he leads the Gut Microbiome Interaction Lab (Gumi lab) and maintains active research programs in microbial physiology and food safety. His research spans bacterial sporulation/germination mechanisms, antibiotic resistance evolution, and gut microbiome dynamics, with emphasis on molecular physiology of spore-formers (Bacillus, Clostridioides). He employs multi-omics approaches (proteomics, metabolomics), single-cell analysis, and molecular genetics to investigate stress adaptation, host-microbe interactions, and food safety applications. Current projects focus on spore germination receptors, bacterial persisters, and microbiome perturbations in Crohn's disease. Analysis of his 2023-2025 publications reveals consistent themes: molecular dissection of germinant receptors (particularly GerAB), evolutionary dynamics of antibiotic resistance, and integrated omics for gut microbiome disorders. His work bridges fundamental spore physiology with translational applications in food safety and clinical microbiology, featuring quantitative single-cell methods and systems-level modeling of microbial communities. Professor Brul actively mentors PhD students through multiple open projects including spore germinant receptor functioning, bacterial persister analysis related to healthcare resistance, and proteome-metabolome structural analysis of gut-relevant spore formers. He collaborates on large-scale programs investigating microbiome stability, antimicrobial mechanisms, and synthetic microbial communities, with strong emphasis on experimental innovation and interdisciplinary approaches.

• Microbial Food Safety
• Bacterial Spore Biology
• Antibiotic Resistance
• +3 more

Professor Jingyuan Yang-Fu is a distinguished faculty member at the University of Groningen's Faculty of Medical Sciences/UMCG, where she leads research at the Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI). Her work significantly contributes to UN Sustainable Development Goals through groundbreaking research on gut microbiome and human health interactions. With over 211 research outputs and 81 professional activities, she has established herself as a leading expert in gastrointestinal immunology and microbial genetics. Yang-Fu's research interests focus on gut microbiome dynamics, host-microbe interactions, and their implications for human health. Her work spans multiple disciplines including microbial genetics, immunology, metabolomics, and population health. She investigates how gut microbiome profiles influence metabolic health across the lifespan, the role of microbial genetic diversity in disease states, and the mechanisms underlying inflammatory bowel diseases. Her research has revealed important connections between blood type, gut microbes, and health outcomes, as well as strain-level variations in microbiome composition related to conditions like coeliac disease. Her recent publications demonstrate significant trends in analyzing microbial genetic structure at unprecedented resolution, examining longitudinal development of gut ecosystems from infancy, and exploring the relationship between geographic location and host health. Yang-Fu's work increasingly focuses on translating microbiome research into personalized medicine applications and understanding the microbiome's role in healthy ageing. Elected member of KHMW (February 2025) Ammodo Science Award (2023) AMMODO Science Award (2023) Highly Cited Researcher (2022) Scientist of the Year (2022) Professor Yang-Fu has supervised 11 research projects and maintains an active research program with extensive collaborations across international boundaries. Her work has attracted significant attention, with numerous media features in outlets like Time.news and coverage across multiple social media platforms. She leads the 3GI research group which focuses on gastrointestinal genetics and immunology, with particular emphasis on understanding the complex interactions between host genetics and gut microbial communities.

• Gut Microbiome
• Genetics
• Microbiome
• +7 more

Dr. Frans van der Heide is an active researcher at the University Medical Center Groningen, part of the University of Groningen, specializing in transplantation medicine with a focus on intestinal and liver transplantation. His work significantly contributes to advancing knowledge in graft rejection mechanisms, molecular signatures in transplanted tissue, and clinical management of transplant patients. His research interests span Transplantation Medicine, Gastroenterology, Hepatology, Intestinal Surgery, Immunology, Liver Diseases, and Inflammatory Bowel Disease . Dr. van der Heide's work particularly examines cellular and molecular signatures of intestinal grafts, biological therapies for graft rejection, and clinical management strategies for complex transplant cases including those with primary sclerosing cholangitis and Crohn's disease. Analysis of his recent publications reveals a strong focus on Molecular mechanisms of graft acceptance and rejection Clinical trials for improving post-transplant outcomes Diagnostic approaches for transplant-related complications Management of rare conditions affecting transplant candidates His research demonstrates interdisciplinary collaboration across gastroenterology, surgery, immunology, and hematology. Dr. van der Heide has contributed to 17 research outputs including 12 articles, 2 commentaries, 1 meeting abstract, 1 letter, and 1 review article. His work is cited across multiple publications and has attracted attention from academic researchers and clinicians as evidenced by social media mentions and Mendeley readership.

• Transplantation Medicine
• Gastroenterology
• Hepatology
• +4 more

Sarah Pringle is a Researcher at the University of Groningen , affiliated with the Faculty of Medical Sciences and the Translational Immunology Groningen (TRIGR) . Her work focuses on salivary gland dysfunction in autoimmune and treatment-induced contexts. Education: B.Sc. Hons in International Microbiology and Immunology from University of Leeds (2004) Doctorate in Generation of cartilage for arthritic joint repair from King's College Hospital (2010) Her research explores Sjögren’s Disease pathogenesis, stem cell-based therapies for salivary gland regeneration, and organoid modeling of autoimmune conditions. Key methodologies include transcriptomics and histological analysis. Recent publications emphasize salivary gland organoids , radiation-induced senescence , and stem cell functionality across autoimmune diseases like Crohn’s and SLE. Articles reveal interdisciplinary work in immunology , regenerative medicine , and clinical rheumatology . Scientific Awards: Reumafonds Long Term Research Program Grant (2019) EULAR Abstract Award Basic Science (2020) Gordon Research Conference Travel Grant (2019) Multiple competitive fellowships for Sjögren’s-related stem cell research She supervises PhD students and collaborates internationally on autoimmune disease projects.

• Sjögren's Disease
• Salivary Gland Function
• Stem Cell Therapy
• +6 more

Frans Vos is an Associate Professor at the Department of Imaging Physics (Faculty of Applied Sciences) at Delft University of Technology, with a joint appointment at the Department of Radiology at ErasmusMC. His academic background combines Computer Science and Medical Informatics (University of Amsterdam, 1993) with a PhD in corneal shape measurement techniques (Vrije Universiteit Amsterdam, 1998). Joint faculty: TU Delft & ErasmusMC Specialization: Medical Image Analysis Key contributions: Imaging biomarkers, AI algorithms, and physics-informed modeling His research focuses on improving medical imaging for disease prevention and therapy optimization, particularly through integration of imaging physics with clinical applications. He led the FP7 VIGOR++ project (2016 completion) on Crohn's disease MRI assessment. The 2023-2024 publications reveal ongoing work in glioma characterization, radiology AI implementation frameworks, and 3D ultrasound embryo staging. Over his career, he has supervised 20 PhD students and 60 undergraduates in medical image processing. Current affiliations include the Imaging Physics (ImPhys) department at TU Delft and Radiology at ErasmusMC, with lab infrastructure and clinical translation as key focus areas.

• Medical Image Analysis
• Quantitative MR Imaging
• Imaging Biomarkers
• +3 more

Noortje Festen is an Associate Professor at the University of Groningen, Faculty of Medical Sciences, working within the Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI). She has established herself as a prominent researcher in inflammatory bowel disease (IBD) with significant contributions to understanding the genetic and environmental factors influencing gastrointestinal disorders. Her educational background isn't explicitly detailed in the provided text, but her research leadership position suggests advanced medical and scientific training. Dr. Festen's research focuses primarily on inflammatory bowel disease, with specific expertise in Crohn's disease, ulcerative colitis, gut microbiome interactions, and genetic factors influencing disease progression. Her work spans from fundamental genetic research to clinical applications, particularly examining how diet, environment, and genetics interact in IBD pathogenesis. She has been instrumental in large-scale collaborative projects like the 1000IBD project, which provides multi-omics data from 1000 inflammatory bowel disease patients. Analysis of her recent publications (2025) reveals a strong focus on translational research, with studies examining diet-flare relationships in IBD, gene-environment interactions, and applications of genomic analysis in transplantation medicine. Her work demonstrates interdisciplinary approaches combining genetics, microbiome analysis, and clinical outcomes. Dr. Festen has contributed to significant research outputs including 128 publications, with recent work appearing in high-impact journals such as Journal of Crohn's & Colitis, Hepatology Communications, and Journal of Thrombosis and Haemostasis. Her research has garnered citations and captures readers across multiple platforms. She actively supervises graduate students, having served as co-supervisor for PhD research on gut mucosal gene expression in inflammatory bowel disease. Her collaborative network extends across multiple institutions, as evidenced by her involvement in the TransplantLines Investigators consortium and other multi-center studies. Dr. Festen leads research in the 3GI institute, focusing on the intersection of genetics, immunology, and gastrointestinal diseases. Her team contributes to both clinical research and fundamental science, with particular emphasis on personalized medicine approaches for inflammatory bowel disease patients.

• Inflammatory Bowel Disease
• Crohn's Disease
• Ulcerative Colitis
• +4 more

Prof. Klaas Nico Faber is a Professor of Experimental Hepatology and Gastroenterology at the University of Groningen, affiliated with the University Medical Center Groningen (UMCG). He leads research at the Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI). His work focuses on liver fibrosis, inflammatory bowel disease (IBD), microbiome interactions, and organoid models. He has authored over 224 publications, including studies on Vedolizumab treatment in allograft enteropathy and the role of microbial metabolism in colonic health. His research contributes to UN Sustainable Development Goals related to health and well-being. Research interests include the pathophysiology of IBD, liver disease mechanisms, and translational therapies. Notable projects investigate microbial influences on gut health, fibrosis pathways, and biomarker development. Collaborations span global institutions, reflecting his expertise in gastrointestinal genetics and immunology. Recent articles highlight breakthroughs in microbiome genomics, fibrogenesis modeling, and therapeutic targets for IBD. Awards and recognitions are not explicitly listed, but his extensive peer-reviewed output underscores his academic impact. He supervises research in experimental gastroenterology and mentors teams at 3GI.

• Experimental Hepatology
• Gastroenterology
• Liver Fibrosis
• +3 more